Truist Financial Corp Acquires 8,299 Shares of Agilent Technologies, Inc. $A

Truist Financial Corp boosted its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 28.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,822 shares of the medical research company’s stock after acquiring an additional 8,299 shares during the period. Truist Financial Corp’s holdings in Agilent Technologies were worth $5,146,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in A. Massachusetts Financial Services Co. MA grew its holdings in Agilent Technologies by 13.8% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock worth $1,925,064,000 after acquiring an additional 1,713,216 shares in the last quarter. AQR Capital Management LLC grew its holdings in Agilent Technologies by 424.1% during the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock worth $240,956,000 after acquiring an additional 1,652,244 shares in the last quarter. Ameriprise Financial Inc. grew its holdings in Agilent Technologies by 132.2% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock worth $277,807,000 after acquiring an additional 1,340,161 shares in the last quarter. SG Americas Securities LLC grew its holdings in Agilent Technologies by 3,091.1% during the 4th quarter. SG Americas Securities LLC now owns 808,215 shares of the medical research company’s stock worth $109,974,000 after acquiring an additional 782,888 shares in the last quarter. Finally, Lazard Asset Management LLC lifted its position in shares of Agilent Technologies by 639.4% during the second quarter. Lazard Asset Management LLC now owns 678,718 shares of the medical research company’s stock valued at $80,093,000 after buying an additional 586,931 shares during the last quarter.

Agilent Technologies Trading Down 0.1%

Shares of Agilent Technologies stock opened at $115.52 on Monday. The company has a current ratio of 2.07, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44. Agilent Technologies, Inc. has a 12-month low of $106.79 and a 12-month high of $160.27. The firm has a market capitalization of $32.65 billion, a price-to-earnings ratio of 25.50, a PEG ratio of 2.43 and a beta of 1.22. The firm’s 50 day simple moving average is $115.99 and its two-hundred day simple moving average is $131.97.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The company had revenue of $1.80 billion for the quarter, compared to analyst estimates of $1.81 billion. During the same quarter in the previous year, the company posted $1.31 EPS. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Analysts predict that Agilent Technologies, Inc. will post 5.95 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st were paid a dividend of $0.255 per share. The ex-dividend date was Tuesday, March 31st. This represents a $1.02 dividend on an annualized basis and a yield of 0.9%. Agilent Technologies’s dividend payout ratio is presently 22.52%.

Analysts Set New Price Targets

Several research firms have commented on A. Wall Street Zen lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Saturday. HSBC began coverage on shares of Agilent Technologies in a research report on Tuesday, January 20th. They set a “buy” rating and a $180.00 price target for the company. TD Cowen decreased their price target on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Morgan Stanley decreased their price target on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. Finally, Barclays decreased their price target on shares of Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, Agilent Technologies has an average rating of “Buy” and a consensus price target of $163.71.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.